UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The burden of bleeding in haemophilia: is one bleed too many?

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-07, Vol.20 (4), p.459-463

2014

Volltextzugriff (PDF)

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

Journal of thrombosis and haemostasis, 2011-04, Vol.9 (4), p.700-710

2011

Volltextzugriff (PDF)

VWF/FVIII concentrates in high-risk immunotolerance: the RESIST study

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-12, Vol.13 (s5), p.73-77

GRINGERI, A.

2007

Volltextzugriff (PDF)

Pain management in patients with haemophilia: a European survey

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.743-752

2012

Volltextzugriff (PDF)

Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.e344-e358

2015

Volltextzugriff (PDF)

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1256-1265

2010

Volltextzugriff (PDF)

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.e170-e179

2017

Volltextzugriff (PDF)

Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-07, Vol.24 (4), p.570-577

2018

Volltextzugriff (PDF)

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.300-306

2015

Volltextzugriff (PDF)

The multiple benefits of sport in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.341-343

2018

Volltextzugriff (PDF)

European principles of haemophilia care

Haemophilia : the official journal of the World Federation of Hemophilia, 2008-03, Vol.14 (2), p.361-374

2008

Volltextzugriff (PDF)

Comparative analysis of marketed factor VIII products: recombinant products are not alike vis‐a‐vis soluble protein aggregates and subvisible particles

Journal of thrombosis and haemostasis, 2018-06, Vol.16 (6), p.1176-1181

2018

Volltextzugriff (PDF)

Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three‐year follow‐up of the AHEAD (Advate in HaEmophilia A outcome Database) study

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.85-96

2018

Volltextzugriff (PDF)

Bypassing agent regimens and costs for prophylaxis in patients with inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-11, Vol.15 (6), p.1336-1337

GRINGERI, A.

2009

Volltextzugriff (PDF)

Tertiary prophylaxis in adults: is there a rationale?

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.722-728

2012

Volltextzugriff (PDF)

Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers)

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-12, Vol.13 (s5), p.65-68

2007

Volltextzugriff (PDF)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.747-766

2010

Volltextzugriff (PDF)

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.736-743

2013

Volltextzugriff (PDF)

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Journal of thrombosis and haemostasis, 2009-05, Vol.7 (5), p.780-786

2009

Volltextzugriff (PDF)

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.96-102

2016

Volltextzugriff (PDF)

Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-11, Vol.11 (6), p.611-619

2005

Volltextzugriff (PDF)

Health-related quality of life and psychological well-being in elderly patients with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.345-352

2012

Volltextzugriff (PDF)

Ultrasonography of haemophilic arthropathy

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-05, Vol.18 (3), p.364-368

2012

Volltextzugriff (PDF)

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-07, Vol.17 (4), p.630-635

2011

Volltextzugriff (PDF)

Haemophilia Care in Europe: the ESCHQoL study

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (5), p.729-737

2012

Volltextzugriff (PDF)

1 – 25 von 758

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(662)
Mit Volltextzugriff
(630)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Haemophilia : The Official Journal Of The World Federation Of Hemophilia
(73)
Digestive And Liver Disease
(54)
Blood
(39)
Hpb
(28)
Value In Health
(26)
Journal Of Hepatology
(25)
Transplantation Proceedings
(25)
Haemophilia
(24)
British Journal Of Haematology
(17)
Affilia
(13)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The burden of bleeding in haemophilia: is one bleed too many?

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)

VWF/FVIII concentrates in high-risk immunotolerance: the RESIST study

Pain management in patients with haemophilia: a European survey

Health-related quality of life assessment in haemophilia patients on prophylaxis therapy: a systematic review of results from prospective clinical trials

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma‐derived or recombinant factor VIII concentrates: a systematic review

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement

Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis - new insight provided by pharmacokinetic modelling

The multiple benefits of sport in haemophilia

European principles of haemophilia care

Comparative analysis of marketed factor VIII products: recombinant products are not alike vis‐a‐vis soluble protein aggregates and subvisible particles

Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three‐year follow‐up of the AHEAD (Advate in HaEmophilia A outcome Database) study

Bypassing agent regimens and costs for prophylaxis in patients with inhibitors

Tertiary prophylaxis in adults: is there a rationale?

Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study

Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy

Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study)

Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors

Health-related quality of life and psychological well-being in elderly patients with haemophilia

Ultrasonography of haemophilic arthropathy

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors

Haemophilia Care in Europe: the ESCHQoL study

Suchergebnisse filtern